Angelo Michele Carella

Angelo Michele Carella

UNVERIFIED PROFILE

Are you Angelo Michele Carella?   Register this Author

Register author
Angelo Michele Carella

Angelo Michele Carella

Publications by authors named "Angelo Michele Carella"

Are you Angelo Michele Carella?   Register this Author

81Publications

2639Reads

13Profile Views

Obinutuzumab or Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Previously Untreated Diffuse Large B-Cell Lymphoma.

J Clin Oncol 2017 Nov 10;35(31):3529-3537. Epub 2017 Aug 10.

Umberto Vitolo, Azienda Ospedaliera Universitaria Città della Salute e della Scienza di Torino, Turin; Angelo Michele Carella, Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS) Azienda Ospedaliera e Universitaria San Martino-IST, Genoa; Antonio Pinto, Istituto Nazionale Tumori, Fondazione G. Pascale, IRCCS, Naples; Maurizio Martelli, Sapienza University, Rome, Italy; Marek Trněný, Charles University, General Hospital, Prague; David Belada, Charles University Hospital, Hradec Králové, Czech Republic; John M. Burke, Rocky Mountain Cancer Centers, Aurora, CO; US Oncology Research, The Woodlands, TX; Neil Chua, Cross Cancer Institute, University of Alberta, Edmonton, Alberta; Laurie H. Sehn, British Columbia Cancer Agency and the University of British Columbia, Vancouver, British Columbia, Canada; Pau Abrisqueta, University Hospital Vall d'Hebron, Barcelona, Spain; Judit Demeter, Semmelweiss University, Budapest, Hungary; Ian Flinn, Sarah Cannon Research Institute; Tennessee Oncology, Nashville, TN; Xiaonan Hong, Fudan University Shanghai Cancer Center, Shanghai; Yuan-Kai Shi, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, Beijing, China; Won Seog Kim, Samsung Medical Center, Sunkyunkwan University School of Medicine, Seoul, Republic of Korea; Yoichi Tatsumi, Kinki University Hospital, Osaka, Japan; Mikkel Z. Oestergaard, Günter Fingerle-Rowson, Olivier Catalani, and Tina Nielsen, F. Hoffman-La Roche, Basel, Switzerland; and Michael Wenger, Genentech, South San Francisco, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.73.3402DOI Listing
November 2017

A Multicenter Phase II Study of Twice-Weekly Bortezomib plus Rituximab in Patients with Relapsed Follicular Lymphoma: Long-Term Follow-Up.

Acta Haematol 2017 4;137(1):7-14. Epub 2016 Nov 4.

Program of Innovative Therapy in Oncology and Hematology, Department of Diagnostic, Clinical Medicine and Public Health, University of Modena and Reggio Emilia, Modena, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000449052DOI Listing
February 2017

Antilymphocyte Globulin for Prevention of Chronic Graft-versus-Host Disease.

N Engl J Med 2016 Jan;374(1):43-53

From the University Medical Center Hamburg-Eppendorf, Hamburg (N.K., C.W., M.H., F.A.), University Hospital Freiburg, Freiburg (J.F.), University Hospital Tübingen, Tübingen (W.B.), and Psy Consult, Frankfurt (A.V.) - all in Germany; Hospital Clinico Universitario, Valencia (C. Solano), Hospital Ramon y Cajal (J.P.O.) and Hospital Universitario Puerta de Hierro Majadahonda (R.D.), Madrid, Servicio de Hematología, Institut Català d'Oncologia, Hospital Universitari Germans Trias i Pujol, Badalona, (C.F.), Hospital de la Santa Creu i Sant Pau, Barcelona (J.S.), and Hospital Virgen de las Nieves, Granada (M.J.) - all in Spain; S. Orsola-Malpighi University Hospital, University of Bologna, Bologna (G.B., F. Bonifazi), Hematology, DISM, University Udine, Udine (F.P.), Azienda Ospedaliera SS Antonio e Biagio e C. Arrigo, Alessandria (M. Pini), Università Federico II di Napoli, Naples (C. Selleri, A.R.), A.O. Bianchi-Melacrino-Morelli, Reggio Calabria (G. Messina), Ospedale Casa Sollievo della Sofferenza IRCCCS, San Giovanni Rotondo (A.M.C.), Azienda Ospedaliera San Carlo, Potenza (M.C.), Azienda Ospedaliera Careggi, Florence (S.G.), Ospedale Santa Croce, e Carle, Cuneo (N.M.), University of Brescia, Department of Clinical and Experimental Sciences, Brescia (D.R.), University of Pisa, Department of Clinical and Experimental Medicine, Pisa (M. Petrini), Programma di Trapianto Emopoietico Metropolitano, Azienda Policlinico-Vittorio Emanuele, Catania (G. Milone), Policlinico G.B. Rossi, Verona (F. Benedetti), Azienda Ospedaliera, Universitaria Ospedale, Bari (D.P.), Ospedale San Gerardo, Monza (E.T.), Policlinico Modena, Modena (F.N.), and Università di Salerno, Salerno (C. Selleri) - all in Italy; Chaim Sheba Medical Center, Tel Hashomer, Ramat-Gan, Israel (A.N.); and Helsinki University Hospital, Helsinki (T.R.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1506002DOI Listing
January 2016

Equivalent outcome of autologous stem cell transplantation and reduced intensity conditioning stem cell transplantation in acute myeloid leukemia patients with t(8;21) translocation?

Acta Haematol 2015 20;133(3):264-5. Epub 2014 Nov 20.

Hematology Division, IRCCS AOU San Martino-IST, Genoa, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000365780DOI Listing
June 2015

Unmanipulated haploidentical transplants compared with other alternative donors and matched sibling grafts.

Biol Blood Marrow Transplant 2014 Oct 5;20(10):1573-9. Epub 2014 Jun 5.

Division of Hematology and Marrow Transplantation, Istituto Ricerca Carattere Scientifico (IRCCS), San Martino Istituto Tumori (IST), Genova, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2014.05.029DOI Listing
October 2014

Autologous transplantation and maintenance therapy in multiple myeloma.

N Engl J Med 2014 Sep;371(10):895-905

From the Myeloma Unit, Division of Hematology, University of Turin (A.P., F.C., F.G., C. Cerrato, M.G., P.O., M.B.), and Unit of Clinical Epidemiology and Centro di Referimento per l'Epidemiologia-Piemonte, Azienda Ospedaliero Universitaria Città della Salute e della Scienza di Torino (A.E., G.C.), Turin, Division of Hematology, Ospedale Ferrarotto, Azienda Policlinico-Ospedale Vittorio Emanuele, University of Catania, Catania (F.D.R.), Hematology, Sapienza University of Rome (M.T.P.), and Cattedra di Ematologia, Ospedale S. Eugenio-University Tor Vergata (T.C.), Rome, Divisione di Ematologia, Ospedale S. Gerardo, Monza (S.P.), La Struttura Complessa di Ematologia, Dipartimento di Ematologia ed Oncologia, Azienda Ospedaliera Niguarda Ca' Granda (A.C.), Hematology and Bone Marrow Transplantation Unit, San Raffaele Scientific Institute (M.M.), and Division of Hematology and Bone Marrow Transplantation, IRCCS Istituto Nazionale dei Tumori-University of Milan (P.C.), Milan, Ematologia, Policlinico Federico II, Naples (L.C.), Clinica di Ematologia, Azienda Ospedaliera Universitaria Ospedali Riuniti di Ancona, Ancona (M.O.), Unità Operativa Complessa Ematologia 1, IRCCS Azienda Ospedaliera Universitaria San Martino-Istituto Nazionale per la Ricerca sul Cancro, Genoa (A.M.C.), Seràgnoli Institute of Hematology, Bologna University School of Medicine, Bologna (E.Z., M.C.), Clinica Ematologia, Dipartimento di Scienze Mediche Sperimentali e Cliniche, Azienda Ospedaliera-Universitaria di Udine, Udine (F.P.), Scientific Direction, IRCCS, Centro di Riferimento Oncologico della Basilicata, Rionero in Vulture (P.M.), and Struttura Complessa Ematologia e Dipartimento Oncologia Medica, Spedali Civili di Brescia, Brescia (C. Crippa) - all in Italy; and the Hematology Division, Hadassah University Hospital, Jerusalem (D.B.Y.), and the Hematology Institute, Chaim Sheba Medical Center, Tel Hashomer (E.R., A.N.) - both in Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1402888DOI Listing
September 2014

SIE, SIES, GITMO revised guidelines for the management of follicular lymphoma.

Am J Hematol 2013 Mar 22;88(3):185-92. Epub 2013 Jan 22.

Istituto di Ematologia ed Oncologia Medica Seragnoli, Università di Bologna, Bologna, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.23372DOI Listing
March 2013

Tracking molecular relapse of chronic myeloid leukemia by measuring Hedgehog signaling status.

Leuk Lymphoma 2013 Feb 5;54(2):342-52. Epub 2012 Sep 5.

Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2012.708752DOI Listing
February 2013

Hodgkin lymphoma: highlights from the 2012 European School of Hematology International Conference.

Expert Rev Hematol 2013 Feb;6(1):35-7

Unità Operativa Complessa Ematologia, Istituto di Ricovero e Cura a Carattere Scientifico, Azienda Ospedaliera Universitaria San Martino, Genova, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/ehm.12.73DOI Listing
February 2013

Role of hematopoietic stem cell transplantation in relapsed/refractory hodgkin lymphoma.

Mediterr J Hematol Infect Dis 2012 2;4(1):e2012059. Epub 2012 Oct 2.

Direttore U.O. Ematologia, IRCCS San Martino, Genova.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4084/MJHID.2012.059DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3499990PMC
November 2012

Durable responses in chronic myeloid leukemia patients maintained with lower doses of imatinib mesylate after achieving molecular remission.

Ann Hematol 2007 Oct 19;86(10):749-52. Epub 2007 Jun 19.

Divisione Ematologia 1, Azienda Ospedaliera Universitaria San Martino, Monoblocco XI piano Ponente, L.go R. Benzi, 10, 16132, Genova, Italy.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00277-007-0326-2
Publisher Site
http://dx.doi.org/10.1007/s00277-007-0326-2DOI Listing
October 2007

Imatinib mesylate in chronic myeloid leukemia.

Curr Stem Cell Res Ther 2007 Sep;2(3):249-51

Division of Hematology I and Stem Cell Transplantation Unit, Azienda Ospedaliera Universitaria San Martino, Genoa, Italy.

View Article

Download full-text PDF

Source
September 2007

Imatinib mesylate, a selective inhibitor of BCR-ABL, in chronic myeloid leukemia.

Expert Rev Anticancer Ther 2007 Mar;7(3):249-51

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/14737140.7.3.249DOI Listing
March 2007

The significance of minimal residual disease in stem cell grafts and the role of purging: is it better to purge in vivo or in vitro?

Acta Haematol 2005 ;114(4):206-13

Division of Hematology and Stem Cell Unit, IRCCS S. Giovanni Rotondo and Division of Hematology, Azienda Ospedaliera Universitaria San Martino, Genova, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000088411DOI Listing
December 2005

Calcitriol increases burst-forming unit-erythroid proliferation in chronic renal failure. A synergistic effect with r-HuEpo.

Nephron Clin Pract 2003 ;95(4):c121-7

Department of Nephrology and Dialysis, IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000074837DOI Listing
May 2004

Pamidronate for early-stage, untreated myeloma.

J Clin Oncol 2003 Aug;21(16):3177-8; author reply 3178

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2003.99.248DOI Listing
August 2003

Efficacy of a single, weekly dose of recombinant erythropoietin in myelodysplastic syndromes.

Br J Haematol 2003 Jul;122(2):269-71

Unit of Haematology and Stem Cell Transplantation, IRCCS 'Casa Sollievo della Sofferenza', S. Giovanni Rotondo, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1046/j.1365-2141.2003.04435.xDOI Listing
July 2003

Usefulness of RA and RO isoforms of common leukocyte antigen (CD45) for early distinction between normal and abnormal promyelocytes.

Leuk Lymphoma 2002 Sep;43(9):1823-5

Department of Onco-Hematology, San Giovanni di Dio e Ruggi d'Aragona Hospital, 84100 Salerno, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/1042819021000006538DOI Listing
September 2002

Thalidomide abolishes transfusion-dependence in selected patients with myelodysplastic syndromes.

Haematologica 2002 Aug;87(8):884-6

Unit of Hematology and Stem Cell Transplantation, IRCCS Casa Sollievo della Sofferenza Hospital, 71013 S. Giovanni Rotondo, Italy.

View Article

Download full-text PDF

Source
August 2002

Immunophenotypic profile of AC133-positive cells in bone marrow, mobilized peripheral blood and umbilical cord blood.

Leuk Lymphoma 2002 Apr;43(4):869-73

Department of Onco-Hematology, San Giovanni di Dio e Ruggi d'Aragona Hospital, Salerno, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428190290017015DOI Listing
April 2002